The AIDS Clinical Trials Group recently completed a study entitled “A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for HIV Infected Persons Treated for Tuberculosis With CD4 Less Than 200 Cells/mm3” [61]. This evidence concerns the gene CD4 and tuberculosis.